BD BBL™ Enriched Thioglycollate Medium 221787Recalls & reported problems
Becton, Dickinson And Company · BD BBL™ Enriched Thioglycollate Medium, 8 mL, Package of 10 tubes · Class 1
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 30382902217870), received between May 5, 2023 and Jan 30, 2025 — classified as 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Contamination of Device Ingredient or Reagent” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Contamination of Device Ingredient or Reagent1
- Incorrect, Inadequate or Imprecise Result or Readings1
- Product Quality Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Needle Stick/Puncture1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryJan 30, 2025Product Quality Problem; Product Quality Problem
IT WAS REPORTED WHEN USING BD BBL¿ ENRICHED THIOGLYCOLLATE MEDIUM, A STAFF MEMBER WAS TRANSFERRING A PATIENT'S POSITIVE BLOOD CULTURE SAMPLE INTO ONE (1) GLASS TUBE WHEN THE NECK OF THE TUBE BROKE. THE STAFF MEMBER AFTER BEING CUT AND PIERCED, WENT TO A MEDICAL INSTITUTION FOR A BLOOD TEST AND ARE BEING MONITORED. THE PATIENT WHO HAD THE POSITIVE BLOOD CULTURE DID NOT HAVE ANY INFORMATION ABOUT HBV OR HCV INFECTION, SO EVEN IF THE STAFF MEMBER HAD COME INTO CONTACT WITH THE BLOOD, THE RISK OF INFECTION IS THOUGHT TO BE LOW.
Patient problems: Needle Stick/Puncture
MAUDE report 21277513 ↗MalfunctionDec 12, 2023Contamination of Device Ingredient or Reagent; Contamination of Device Ingredient or Reagent
IT WAS REPORTED WHEN USING THE BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1 AND HEMIN CUSTOMER HAS SEEN PARTICLES IN THE LIQUID MEDIUM. THERE WAS NO REPORT OF IMPACT TO PATIENT OR USER.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18314721 ↗MalfunctionMay 5, 2023Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED THAT BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1 AND HEMIN APPEARANCE IS CLOUDY AND WHEN GRAM STAIN WAS PERFORMED GRAM NEGATIVE BACILLI. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: THESE THIO´S ARE SLIGHTLY MORE "CLOUDY" THAN USUAL AND WHEN THEY PERFORM A GRAM STAIN ON THEM, THEY TURN OUT TO BE FULL OF GRAM NEGATIVE BACILLI. THEY ARE GOING TO DO ANOTHER STERILITY CHECK THEIRSELF, BUT THEY HEAR FROM COLLEAGUES IN OTHER LABORATORIES, WITH THE SAME PROBLEM, THAT THEY REMAIN NEGATIVE. NEVERTHELESS, THIS HAS A SERIOUS IMPACT ON THEIR WORKING METHOD. THEY ALWAYS MAKE A GRAM STAINING OF GROWN THIO´S.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16882201 ↗
Other CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL devices
- BD BBL™ Enriched Thioglycollate Medium 221788Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL160 reports
- BD BBL™ Trypticase™ Soy Agar with 5% Sheep Blood and MacConkey II Agar I Plate™ 221291Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL106 reports
- BD BBL™ Trypticase™ Soy Agar with 5% Sheep Blood (TSA II) 221261Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL1 recall51 reports
- BD BBL™ CDC Anaerobe 5% Sheep Blood Agar 221734Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL63 reports
- BD BBL™ Fluid Thioglycollate Medium 221196Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL1 recall4 reports
- BD BBL™ Trypticase™ Soy Broth 221716Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL31 reports
- BD BBL™ Trypticase™ Soy Broth 297354Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL27 reports
- BD BBL™ Trypticase™ Soy Agar (Soybean-Casein Digest Agar) 221283Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL19 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.